Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2016-08-24 Interim / Quarterly Rep…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Resultat for 2. kvartal og 1. halvår for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial report for the second quarter and first half of 2016. It contains comprehensive financial statements, including revenue, EBIT, EBITDA, profit per share, balance sheet data, and detailed operational analysis by region (Europe, USA, Asia). It is not an announcement of a report, but the report itself, and it provides substantive financial data and management analysis, fitting the definition of an Interim/Quarterly Report. Q2 2016
2016-08-24 Norwegian
Resultat for 2. kvartal og 1. halvår for Medistim ASA
Interim / Quarterly Report Classification · 95% confidence The document is a presentation titled 'Medistim ASA Second Quarter 2016' dated August 24th, 2016. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and performance highlights for the second quarter. While it is presented in a slide-deck format, it provides substantive financial data and analysis for an interim period, fitting the definition of an Interim/Quarterly Report (IR). Q2 2016
2016-08-24 Norwegian
Results for second quarter and the first half 2016 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the 2nd quarter and 1st half of 2016. It contains detailed financial statements, including sales, operating profit (EBIT), EBITDA, balance sheet data, and analysis of operational status across different geographic regions (Europe, USA, Asia). It provides comparative numbers for the previous year and discusses business strategy, market trends, and R&D. Since it is a substantive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2016
2016-08-24 English
Resultat for 2. kvartal og 1. halvår for Medistim ASA
Earnings Release Classification · 100% confidence The document text explicitly details financial results for the '2. kvartal og 1. halvår' (2nd quarter and first half year) for Medistim ASA, including revenue (Omsetning), operating profit (Driftsresultatet/EBIT), and earnings per share (Fortjeneste per aksje). This content structure, focusing on period-specific financial performance highlights, strongly indicates an Earnings Release (ER). Although it contains some detail, its brevity (1043 characters) and focus on key figures suggest it is the initial announcement rather than the comprehensive Interim Report (IR). H1 2016
2016-08-24 Norwegian Nynorsk
Results for second quarter and the first half 2016 for Medistim ASA
Earnings Release Classification · 100% confidence The document explicitly states 'Results for second quarter and the first half 2016' and provides key financial metrics like Sales, Operating Profit (EBIT), and Profit per share for the quarter and the first half. This content structure, focusing on period-specific financial highlights immediately following the period end, strongly indicates an Earnings Release (ER), which is defined as the initial announcement of periodical financial results (key highlights only). It is too brief and focused on highlights to be a comprehensive Interim Report (IR). H1 2016
2016-08-24 English
Presentasjon av resultater for 2. kvartal og første halvår 2016 for Medistim ASA
Earnings Release Classification · 90% confidence The document text is very short (507 characters) and announces an upcoming presentation of the results for the 2nd quarter and first half of 2016 for Medistim ASA. It specifies the date, time, and location of this presentation and lists the attending executives (CEO, CFO). This strongly indicates an announcement related to an earnings event, likely preceding the full report or call. Since it is an announcement about the presentation of results, it aligns best with the 'Call Transcript' (CT) if the presentation itself is the focus, or potentially 'Earnings Release' (ER) if it's the initial summary. However, given the context of announcing the presentation event itself, and the short length suggesting it's not the full transcript or the full release, it is most likely an announcement related to the earnings call/presentation. Since 'CT' is defined as the full transcript, and 'ER' is the initial announcement of key highlights, this document is announcing the event where results will be presented. In many contexts, the announcement of the results presentation/call is closely tied to the Earnings Release (ER). Given the options, and that it is announcing the presentation of period results (Q2/H1 2016), ER is the most appropriate fit for the initial communication regarding period results, even if it's announcing the presentation event rather than the full release text itself. If the document were longer and contained the actual results summary, ER would be certain. As it is an announcement about the presentation of period results, ER is the best fit among the provided codes. H1 2016
2016-08-18 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.